semaglutide froze Ozempic face' and hair loss: what evidence is there for weight-loss drug side-effects? | Weight-loss drugs Australian regulator warns of 'rare

real-world data he described as showing that only about one-third of obese patients without diabetes and about half of diabetes patients remain on therapy after a year

Insurance companies have become increasingly restrictive about covering GLP-1 medications for weight management, often requiring documented type 2 diabetes diagnosis or BMI above 30 with obesity-related conditions

The small percentage of negative reviews in the visible set cite difficulty reaching support, a packaging concern, and the guarantee/refund conflict described in the section above

2) They reverse the signs of aging, or so the cosmetic companies claim on their different products